A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world’s first commercialization of Nobel Prize-winning stem cell research.

Scientists have developed a new imaging technique that uses a novel contrast mechanism in bioimaging to merge the strengths of two powerful microscopy methods, allowing researchers to see both the ...